Clinical Impact of BIOFIRE SPOTFIRE Respiratory Panels

This technical report discusses the clinical impact of the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panels, which are designed for symptom-driven testing of upper respiratory tract infections (URTIs). It outlines the significant global health burden posed by URTIs, noting that they are the most frequent human illnesses and can lead to serious complications. The report documents the challenges associated with symptom-based diagnosis, including overlapping clinical signs among multiple pathogens and the high rate of unnecessary antibiotic prescriptions. The BIOFIRE SPOTFIRE R/ST Panels facilitate faster and more accurate diagnosis through multiplex PCR testing, which is recommended for high-risk patients. The report presents evidence of improved clinical decision-making, reduced healthcare costs, and enhanced patient outcomes associated with the use of these panels. Additionally, it emphasizes the importance of antimicrobial stewardship and the reduction of inappropriate antibiotic use through targeted therapy enabled by the panels.